• By Beth Allan, Deanna Kamienski, Maureen Riordan, Amanda Micklus, and Steven Muntner
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Deal-making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in April 2017.
Quotient Ltd. netted $45.4mm through a public sale of 8mm ordinary shares (including the overallotment) at $6. Funds will support ongoing scale-up and future commercialization of the company's MosaiQ automated transfusion diagnostics platform. (Apr.)
Investment Banks/Advisors: BTIG LLC; Jefferies & Co. Inc.